Global Cell Lysis/Cell Fractionation Industry

Global Cell Lysis/Cell Fractionation Industry

  • April 2021 •
  • 174 pages •
  • Report ID: 5899191 •
  • Format: PDF
Abstract:
- Global Cell Lysis/Cell Fractionation Market to Reach $6 Billion by 2027
- Amid the COVID-19 crisis, the global market for Cell Lysis/Cell Fractionation estimated at US$3.3 Billion in the year 2020, is projected to reach a revised size of US$6 Billion by 2027, growing at aCAGR of 9% over the period 2020-2027. Consumables, one of the segments analyzed in the report, is projected to record 10.4% CAGR and reach US$3.9 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 6.8% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $976.1 Million, While China is Forecast to Grow at 8.3% CAGR
- The Cell Lysis/Cell Fractionation market in the U.S. is estimated at US$976.1 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1 Billion by the year 2027 trailing a CAGR of 8.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.3% and 7.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.2% CAGR.

- Select Competitors (Total 44 Featured) -
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Cell Signaling Technology, Inc.
  • Merck KgaA
  • Miltenyi Biotec GmbH
  • Qiagen NV
  • Qsonica L.L.C.
  • Roche Diagnostics
  • Thermo Fisher Scientific, Inc.